Ikarian Capital’s ESSA Pharma EPIX Stock Holding History

Ikarian Capital’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-264,868	Closed	-$7.69M	–	240
2021 Q1	$7.69M	Buy	+264,868	New	+$6.16M	0.26%	83

Other funds holding EPIX

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Ikarian Capital's EPIX Position: Q2 2021 in Review

Ikarian Capital sold out of ESSA Pharma (EPIX) in Q2 2021, closing a stake of 264,868 shares — an estimated $7.69M sold.

Ikarian Capital first reported a position in EPIX in Q1 2021 and held it in 1 quarter. The position peaked at $7.69M in Q1 2021. 80 funds tracked by Wall St. Rank hold EPIX as of Q2 2021.

Ikarian Capital reported no remaining ESSA Pharma position as of Q2 2021 after selling out during the quarter.
Ikarian Capital sold 264,868 ESSA Pharma shares in Q2 2021, an estimated $7.69M.
Ikarian Capital first reported a position in ESSA Pharma in Q1 2021 and held it in 1 quarter.
Ikarian Capital's ESSA Pharma position peaked at $7.69M in Q1 2021.
80 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.